Objective. Tachyarrhythmias, after coronary artery bypass graft (CABG) surgery, develop in 11%–40% of patients. Surgery technique (on-pump or off-pump) might affect incidence of post-CABG tachyarrhythmias. Methods. The study included 60 patients undergoing CABG (≥2 grafts) with left ventricle ejection fraction (LV EF) >40%. Patients were divided into two groups equally: group A (on-pump) and group B (off-pump). Patients were subjected to electrocardiographic monitoring (7 days postoperatively), transthoracic echocardiography, with recording of surgical details and complications. Results. Data collected between December 2012 and May 2013 showed no significant difference between two groups regarding incidence of postoperative tachyarrhythmias with statistically significant higher incidence of supraventricular tachycardia in group B ( ) and a trend towards higher incidence of atrial fibrillation in group A. Patients who developed postoperative tachyarrhythmias in group A showed higher prevalence of family history of coronary artery disease and higher incidence of postoperative chest infections ( ), while those in group B showed higher mean LV EF (pre- and postoperatively) ( ). Data were statistically described in terms of mean ± standard deviation. Comparison of numerical and categorical variables was done using Student’s - and Chi-square tests, respectively. Conclusion. Adopting off-pump CABG technique is not associated with less incidence of post-operative tachyarrhythmias, as compared to on-pump technique. 1. Introduction Surgery for coronary artery disease is known as coronary artery bypass graft (CABG) surgery. It was first performed in 1967 by Kolesov and is still the leading heart operation performed today [1]. Surgeons use cardiopulmonary bypass machine (also known as the heart-lung machine) for on-pump CABG [2]. Complications of on-pump CABG, especially stroke and decrease in higher mental functions, spurred the development of off-pump technique [1]. Up to 30% of patients develop atrial fibrillation (Af) after CABG, mostly benign and self-terminating. Postoperative arrhythmias are associated with prolonged hospital stay, hemodynamic instability, and thromboembolism [3]. The primary goal of off-pump CABG surgery is to provide an equally comprehensive operation as the conventional operation. Patient selection plays an important role in success of off-pump CABG (OPCAB). Patients with poor ejection fraction, cardiomegaly, cardiogenic shock or malignant arrhythmias are at high risk for OPCAB [4]. 2. Methods 2.1. Study Design and Data Collection Sixty
References
[1]
P. S. Shekar, “On-pump and off-pump coronary artery bypass grafting,” Circulation, vol. 113, no. 4, pp. e51–e52, 2006.
[2]
T. Schachner, A. Zimmer, G. Nagele, G. Laufer, and J. Bonatti, “Risk factors for late stroke after coronary artery bypass grafting,” Journal of Thoracic and Cardiovascular Surgery, vol. 130, no. 2, pp. 485–490, 2005.
[3]
S. F. Aranki, D. P. Shaw, D. H. Adams et al., “Predictors of atrial fibrillation after coronary artery surgery: current trends and impact on hospital resources,” Circulation, vol. 94, no. 3, pp. 390–397, 1996.
[4]
I. Javed, G. Abdul, S. Ahmad, et al., “Post operative arrhythmias after coronary artery bypass grafting, a comparison between off pump and on pump CABG,” Journal of Ayub Medical College, vol. 22, no. 3, pp. 122–129, 2010.
[5]
M. Pastuszek, I. Kowalik, G. Religa et al., “Influence of cardiopulmonary bypass on risk of AF after coronary artery bypass grafting,” Przegl？d lekarski, vol. 62, no. 12, pp. 1358–1361, 2005.
[6]
A. D. Maslow, M. M. Regan, S. Heindle, P. Panzica, W. E. Cohn, and R. G. Johnson, “Postoperative atrial tachyarrhythmias in patients undergoing coronary artery bypass graft surgery without cardiopulmonary bypass: a role for intraoperative magnesium supplementation,” Journal of Cardiothoracic and Vascular Anesthesia, vol. 14, no. 5, pp. 524–530, 2000.
[7]
D. C. Cheng, D. Bainbridge, J. E. Martin, and R. J. Novick, “Does off-pump coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with conventional coronary artery bypass? A meta-analysis of randomized trials,” Anesthesiology, vol. 102, no. 1, pp. 188–203, 2005.
[8]
D. N. Wijeysundera, W. S. Beattie, G. Djaiani et al., “Off-pump coronary artery surgery for reducing mortality and morbidity: meta-analysis of randomized and observational studies,” Journal of the American College of Cardiology, vol. 46, no. 5, pp. 872–882, 2005.
[9]
C. H. M？ller, L. Penninga, J. Wetterslev, D. A. Steinbrüchel, and C. Gluud, “Clinical outcomes in randomized trials of off- vs. on-pump coronary artery bypass surgery: Systematic review with meta-analyses and trial sequential analyses,” European Heart Journal, vol. 29, no. 21, pp. 2601–2616, 2008.
[10]
S. F. Marasco, J. Goldblatt, M. McDonald, and J. TatOuliS, “No decrease in incidence of atrial fibrillation in patients undergoing off-pump coronary artery bypass grafting,” Heart Lung and Circulation, vol. 11, no. 2, pp. 102–106, 2002.
[11]
M. Budeus, P. Feindt, E. Gams, H. Wieneke, R. Erbel, and S. Sack, “Risk factors of ventricular tachyarrhythmias after coronary artery bypass grafting,” International Journal of Cardiology, vol. 113, no. 2, pp. 201–208, 2006.
[12]
J. S. Steinberg, A. Gaur, R. Sciacca, and E. Tan, “New-onset sustained ventricular tachycardia after cardiac surgery,” Circulation, vol. 99, no. 7, pp. 903–908, 1999.
[13]
R. Ascione, B. C. Reeves, K. Santo, N. Khan, and G. D. Angelini, “Predictors of new malignant ventricular arrhythmias after coronary surgery: A case-control study,” Journal of the American College of Cardiology, vol. 43, no. 9, pp. 1630–1638, 2004.
[14]
K. Wenke, M. H. A. Parsa, M. Imhof, and B. M. Kemkes, “Efficacy of metoprolol in prevention of supraventricular arrhythmias after coronary artery bypass grafting,” Zeitschrift fur Kardiologie, vol. 88, no. 9, pp. 647–652, 1999.
[15]
R. Davison, R. Hartz, and K. Kaplan, “Prophylaxis of supraventricular tachyarrhythmia after coronary bypass surgery with oral verapamil: a randomized, double-blind trial,” Annals of Thoracic Surgery, vol. 39, no. 4, pp. 336–339, 1985.
[16]
S. A. Mills, G. V. Poole Jr., R. H. Breyer, et al., “Digoxin and propranolol in the prophylaxis of dysrhythmias after coronary artery bypass grafting,” Circulation, vol. 68, no. 3, pp. II222–II225, 1983.
[17]
A. Sezai, T. Nakai, M. Hata, et al., “Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: A Pilot Study,” The Journal of Thoracic and Cardiovascular Surgery, vol. 144, no. 5, pp. 1241–1248, 2012.
[18]
T. Kinoshita, T. Asai, O. Nishimura et al., “Statin for prevention of atrial fibrillation after off-pump coronary artery bypass grafting in Japanese patients,” Circulation Journal, vol. 74, no. 9, pp. 1846–1851, 2010.
[19]
F. Nardi, M. Diena, P. P. Caimmi et al., “Relationship between left atrial volume and atrial fibrillation following coronary artery bypass grafting,” Journal of Cardiac Surgery, vol. 27, no. 1, pp. 128–135, 2012.
[20]
J.-F. Légaré, K. J. Buth, S. King et al., “Coronary bypass surgery performed off pump does not result in lower in-hospital morbidity than coronary artery bypass grafting performed on pump,” Circulation, vol. 109, no. 7, pp. 887–892, 2004.
[21]
G. J. Van Der Heijden, H. M. Nathoe, E. W. L. Jansen, and D. E. Grobbee, “Meta-analysis on the effect of off-pump coronary bypass surgery,” European Journal of Cardio-thoracic Surgery, vol. 26, no. 1, pp. 81–84, 2004.
[22]
A. Diegeler, J. B？rgermann, U. Kappert, et al., “Off-pump versus on-pump coronary-artery bypass grafting in elderly patients,” The New England Journal of Medicine, vol. 368, no. 13, pp. 1189–1198, 2013.
[23]
D. Anno, B. Jochen, K. Utz, et al., “The German Off-Pump Coronary Artery Bypass Grafting in Elderly Patients (GOPCABE) study,” The New England Journal of Medicine, vol. 368, no. 13, pp. 1189–1198, 2013.
[24]
M. E. Brizzio, A. Zapolanski, R. E. Shaw, J. S. Sperling, and B. P. Mindich, “Stroke-related mortality in coronary surgery is reduced by the off-pump approach,” Annals of Thoracic Surgery, vol. 89, no. 1, pp. 19–23, 2010.
[25]
R. Mikkola, J. Gunn, J. Heikkinen, et al., “Use of blood products and risk of stroke after coronary artery bypass surgery,” Blood Transfusion, vol. 10, no. 4, pp. 490–501, 2012.
[26]
M. Hecht-Dolnik, H. Barkan, A. Taharka, and J. Loftus, “Hetastarch increases the risk of bleeding complications in patients after off-pump coronary bypass surgery: a randomized clinical trial,” Journal of Thoracic and Cardiovascular Surgery, vol. 138, no. 3, pp. 703–711, 2009.
